Drugs / LUMEFANTRIN
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01150344 Comparator | Jul 2010 → Apr 2014 | malaria | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LUMEFANTRIN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01150344 ↗ |
| Route | Oral | “4 X (20mg artemether + 120 mg lumefantrine) per os twice a day on 3 days as H0, H8, H24, H36, H48 and H60” NCT01150344 ↗ |